An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

Completed · Phase 2 · Has a placebo group

Conditions studied: Subcutaneous Abdominal Adiposity

In brief

This is a double-masked evaluation of the safety and efficacy of LIPO-102 for the reduction of subcutaneous abdominal adiposity.

Key facts

Study ID

NCT01096979

Run by

Neothetics, Inc

People needed

60

Starts

2009-10-01

Expected to finish

2010-03-01

Last updated by the study team

2015-03-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or non pregnant female
• Good general health
• Sufficient abdominal fat for injections
• Signed informed consent
• BMI greater than or equal to 18 and less than 28 kg/m2
• History of stable weight in past 3 months

You may not qualify if…

• Known hypersensitivity to study drugs
• Treatment with an investigational agent within 30 days of first dose

Where it is running

• Study site — Anaheim, California, United States
• Study site — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.